Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Writing · Document Types & Audience Fit

Health and Medical Writing: Matching Document Type to Audience and Standard

The competency model of the American Medical Writers Association and US federal plain-language law both treat medical writing as a set of genres with different audiences and legal standards rather than a single skill. For this reason, a clinical study report, a patient leaflet and a manuscript for peer review follow entirely different conventions even when they describe the same trial.

Pubrica AcademyWritten by a medical writing specialist Reviewed bya regulatory writing reviewer Published10 October 2026 Last checked10 October 2026 Reading time7 minutes Sources10 peer-reviewed

Health and medical writing comprises a range of distinct document types (regulatory submissions, clinical study reports, manuscripts for peer-reviewed journals and patient-facing materials) that can describe the same underlying data while following entirely different structural, stylistic and legal rules. The American Medical Writers Association (AMWA) formalises this breadth in its competency model, which defines specialised skill areas for regulatory writing, scientific publications and patient education materials as separate competencies rather than variations on one general writing skill, and U.S. federal plain-language requirements add a distinct legal standard that applies specifically to patient- and consumer-facing health materials.

Learning objectives

  • The distinct document types within medical writing and the audience that each serves
  • Why regulatory writing and journal-manuscript writing follow different structural conventions despite reporting the same trial
  • What the US Plain Writing Act and plain-language standards require of patient-facing materials

Common misconceptions

  • “A skilled medical writer can produce any type of medical document equally well using the same general approach.” The certification and competency framework of the American Medical Writers Association treats regulatory writing, scientific and medical publications, and patient education materials as distinct specialisation tracks with different required competencies, reflecting the fact that these document types differ in structure and audience and, in some cases, are subject to distinct legal or regulatory standards.

Document types and their intended audiences

Regulatory medical writing produces documents such as clinical study reports, investigator brochures and submission dossiers, intended for regulatory reviewers at agencies such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) and structured around the specific data and safety reporting formats that those agencies require. Scientific and medical publication writing produces manuscripts for peer-reviewed journals, structured around IMRaD (Introduction, Methods, Results and Discussion) and the reporting guideline relevant to the study design (such as CONSORT, PRISMA or STROBE), and intended for a professional scientific or clinical audience capable of evaluating methodology directly. Patient education writing produces materials such as medication information leaflets, informed consent documents and condition-specific guides, intended for a lay audience and subject to health-literacy and plain-language standards rather than professional reporting conventions. AMWA’s competency model treats these as separate specialisations, each with its own certification track, structural conventions and body of professional practice, rather than as general applications of medical knowledge to documents of different lengths1.

Differently structured documents arising from a single trial

A single clinical trial can generate a clinical study report for regulatory submission, a manuscript for a peer-reviewed journal and a patient-facing summary, each of which follows fundamentally different rules despite describing the same underlying dataset. The ICH E3 guideline specifies a detailed, standardised structure for clinical study reports, covering every protocol amendment, every adverse event by severity and relatedness, and full statistical analyses, because regulatory reviewers require a complete, auditable record on which to base an approval decision2. A journal manuscript reporting the same trial, by contrast, is constrained by word limits and reader attention, and follows the more selective reporting requirements of CONSORT, which focus on the methodological and outcome details that a scientific reader needs to evaluate validity rather than every operational detail that a regulator requires3. Neither document is a shortened or expanded version of the other; each is independently structured to serve the decision-making needs of its specific reader.

Distinction between the roles of the medical writer and the researcher

The role of a professional medical writer on a study, particularly in company-sponsored clinical research, is defined as a writing and editorial contribution rather than a substitute for scientific authorship, a distinction formalised in the Good Publication Practice (GPP) guidelines. The GPP3 guidelines, authored by Battisti and colleagues on behalf of the International Society for Medical Publication Professionals, state explicitly that professional medical writers should assist authors in developing and drafting a publication under their direction and on the basis of their own data and interpretation, that writers must be acknowledged, and that writer involvement does not by itself qualify the writer for authorship under the International Committee of Medical Journal Editors (ICMJE) authorship criteria, since those criteria require substantial contribution to conception, analysis and interpretation, not drafting assistance alone6. This distinction matters in practice because it establishes the standard against which “ghostwriting”, in which a professional writer’s substantial contribution goes undisclosed, is identified and avoided: GPP3 required transparent disclosure of writing and editorial support in the acknowledgements of any publication that used it, so that readers can see who contributed to the drafting of the manuscript, separately from who conducted, and is accountable for, the underlying research6.

The common format for regulatory submission writing

Regulatory writing for drug and medical device submissions follows a standardised international structure, the Common Technical Document (CTD), defined in ICH M4, which organises a submission into five consistent modules (administrative information; summaries; quality data on chemistry, manufacturing and controls; nonclinical study reports; and clinical study reports) used across the major regulatory regions that have adopted it, including the United States, the European Union and Japan7. Writing within this structure is a specialised skill distinct even from the clinical study report writing discussed above, since CTD modules such as the nonclinical overview or the clinical summary require results from multiple individual study reports to be synthesised into module-level summaries that follow formatting and content expectations defined by ICH guidance rather than by the reporting needs of any single study.

The legal standard for patient-facing materials

Patient-facing medical writing operates under a distinct standard grounded in health literacy research and, for U.S. federal agencies, in statute. The Plain Writing Act of 2010 requires U.S. federal agencies to use clear communication that the public can understand and use in official documents, and federal guidance at plainlanguage.gov translates this into specific, verifiable rules: short sentences, common words instead of jargon, active voice, and direct address to the reader4. The health-literacy framework of the U.S. Department of Health and Human Services, part of its Healthy People initiative, defines the practical target of this standard as the degree to which individuals can find, understand, and use basic health information to make decisions, explicitly connecting document clarity to health outcomes rather than treating it as a stylistic refinement5. For this reason, a patient-facing leaflet describing the same trial data as a dense clinical study report or journal article will typically be written at a far lower reading grade level and will avoid the technical vocabulary on which both of those document types rely.

Translation of patient materials as a distinct skill

When patient-facing materials must reach a non-English-speaking population, word-for-word translation is not sufficient to preserve the plain-language standard discussed above, because idioms, sentence complexity and health-literacy norms vary meaningfully across languages and cultures. The European Medicines Agency’s guidance on the readability of patient package leaflets, developed through its Quality Review of Documents (QRD) process, requires user testing of leaflets with representative patient groups in each target language rather than assuming that a direct translation of an approved English-language leaflet will be equally comprehensible, since literal translation can preserve technical accuracy while failing the comprehension test that the original plain-language leaflet was designed to pass9. For medical writers producing multilingual patient materials, translation and localisation therefore constitute a distinct step in the writing process, with their own testing requirement, rather than a mechanical final conversion applied after the primary-language document is complete.

Use of a shared style manual across document types

Despite the structural differences between regulatory, scientific and patient-facing writing, medical writers working across all three typically rely on a shared foundational style reference, most commonly the AMA Manual of Style, for the mechanical conventions that remain constant regardless of document type: how to format a drug name, how to express a dosage, how to present statistical notation and how to construct a reference list10. This shared layer exists because mechanical correctness, unlike structure and audience targeting, does not need to vary by document type: a milligram abbreviation should be written in the same way whether it appears in a clinical study report, a journal manuscript or (once translated into plain language) a patient leaflet, which is why a single style manual can underpin genre-specific structural guidance such as ICH E3 or CONSORT rather than being replaced for each document type. Teams that draft regulatory, scientific and patient-facing documents from the same trial typically retain one shared style reference for this mechanical layer while applying a different structural template (ICH E3, CONSORT or plain-language guidance) to each deliverable, thereby maintaining mechanical consistency across an otherwise very different set of documents.

Key points

Key points

Regulatory writing, journal-manuscript writing and patient-facing writing are distinct specialisations with their own structural conventions and, in the case of patient materials, distinct legal and health-literacy standards; they are not three lengths of the same underlying skill, which is why the same trial data are legitimately written up in three different ways.

Practical application

Practical application

  1. The intended audience of a document should be identified before its structure is chosen. A regulatory reviewer, a peer-review audience and a patient each expect a different structure and level of technical detail; the document type should be matched to that audience rather than to a single default template.
  2. ICH E3 structure should be used for clinical study reports, and CONSORT, PRISMA or STROBE for journal manuscripts. A manuscript should not be treated as a shortened clinical study report; each follows its own reporting guideline, designed for its specific reader.
  3. Plain-language principles (short sentences, common words and active voice) should be applied to all patient-facing material. Reading grade level and density of technical terminology should be checked specifically for leaflets, consent forms and patient summaries, since these are subject to a health-literacy standard that does not apply to journal manuscripts or regulatory documents.

Frequently asked questions

No. A clinical study report follows the ICH E3 structure, designed for regulatory reviewers who require a complete, auditable record of the trial, including every protocol amendment and the full statistical analysis plan. A journal manuscript follows a reporting guideline such as CONSORT, designed for a scientific audience evaluating methodological validity within space constraints that do not apply to the regulatory document.

AMWA’s credentialing and competency framework recognises distinct specialisation areas, including regulatory writing and medical publications, reflecting the fact that these require different skill sets rather than a single general medical writing competency.

Federal plain-language guidance operationalises it as short sentences, common everyday words instead of technical jargon, active voice, and direct address to the reader (using “you”), with the explicit aim of making a document usable by its intended audience without specialised background knowledge.

Not on the basis of drafting assistance alone. Good Publication Practice guidelines state that writing support does not by itself meet the ICMJE authorship criteria, which require substantial contribution to the conception, analysis and interpretation of the study; writers should instead be transparently acknowledged for their drafting and editorial contribution.

Not necessarily. The EMA’s QRD guidance requires user testing of translated leaflets with representative patient groups, since a literal, technically accurate translation can still fail the comprehension standard that the original plain-language version was designed to meet.

References

  1. American Medical Writers Association. AMWA Medical Writing Certification: Competency Model. read 10 October 2026. View AMWA Certification
  2. International Council for Harmonisation. ICH E3: Structure and Content of Clinical Study Reports. read 10 October 2026. View ICH E3 Guideline
  3. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. read 10 October 2026. View on BMJ
  4. U.S. General Services Administration. Plain Writing Act of 2010 and Federal Plain Language Guidelines. read 10 October 2026. View Plain Language Guidelines
  5. Office of Disease Prevention and Health Promotion, U.S. Department of Health and Human Services. Health Literacy in Healthy People 2030. read 10 October 2026. View on Healthy People 2030
  6. Battisti WP, Wager E, Baltzer L, et al, on behalf of the International Society for Medical Publication Professionals. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Annals of Internal Medicine. 2015;163(6):461-464. read 10 October 2026. View on Annals of Internal Medicine
  7. International Council for Harmonisation. ICH M4: The Common Technical Document. read 10 October 2026. View ICH M4 Common Technical Document
  8. International Committee of Medical Journal Editors. Defining the Role of Authors and Contributors. read 10 October 2026. View ICMJE Authorship Criteria
  9. European Medicines Agency. QRD Convention and Guidance on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use. read 10 October 2026. View EMA QRD Guidance
  10. American Medical Association. AMA Manual of Style: A Guide for Authors and Editors. 11th ed. Oxford University Press. read 10 October 2026. View AMA Manual of Style

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). Health and Medical Writing: Matching Document Type to Audience and Standard. Pubrica. https://pubrica.com/academy/study-guide/health-medical-writing/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Document Type and Audience Match Checklist

This checklist should be completed before drafting any health or medical writing deliverable.

[ ] Identified the document's specific intended reader (regulator, peer reviewer, or patient)
[ ] Selected the correct structural standard (ICH E3, CONSORT/PRISMA/STROBE, or plain-language guidance)
[ ] Confirmed required technical depth matches that reader's actual decision-making needs
[ ] For patient-facing materials, checked reading-grade level and jargon density
[ ] Confirmed no single draft is being reused across document types without restructuring

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica’s medical writing team produces regulatory documents, journal manuscripts and patient-facing materials from the same underlying study data as separate, purpose-built deliverables, each matched to its specific audience and standard.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Writing designed for the intended reader

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.